These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31679427)

  • 1. Potential of Stratified Medicine for High Blood Pressure Management: A Modeling Study Using NHANES Survey Data.
    Porcher R; Tran VT; Blacher J; Ravaud P
    Hypertension; 2019 Dec; 74(6):1420-1427. PubMed ID: 31679427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examination Survey).
    Bress AP; Kramer H; Khatib R; Beddhu S; Cheung AK; Hess R; Bansal VK; Cao G; Yee J; Moran AE; Durazo-Arvizu R; Muntner P; Cooper RS
    Circulation; 2017 Apr; 135(17):1617-1628. PubMed ID: 28193605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Cardiovascular Disease Events Prevented with Adoption of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline.
    Bress AP; Colantonio LD; Cooper RS; Kramer H; Booth JN; Odden MC; Bibbins-Domingo K; Shimbo D; Whelton PK; Levitan EB; Howard G; Bellows BK; Kleindorfer D; Safford MM; Muntner P; Moran AE
    Circulation; 2019 Jan; 139(1):24-36. PubMed ID: 30586736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the Association of the 2017 and 2014 Hypertension Guidelines With Cardiovascular Events and Deaths in US Adults: An Analysis of National Data.
    Bundy JD; Mills KT; Chen J; Li C; Greenland P; He J
    JAMA Cardiol; 2018 Jul; 3(7):572-581. PubMed ID: 29800138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials.
    Basu S; Sussman JB; Rigdon J; Steimle L; Denton BT; Hayward RA
    PLoS Med; 2017 Oct; 14(10):e1002410. PubMed ID: 29040268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nationwide Impact of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guidelines on Stroke Survivors.
    Lekoubou A; Bishu KG; Ovbiagele B
    J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29875135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of early initiation of antihypertensive medications for patients with hypertension or elevated blood pressure.
    Han X; McCombs J; Chu M; Dougherty JS; Fox DS
    J Hypertens; 2019 Jun; 37(6):1276-1284. PubMed ID: 30624365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient Selection for Intensive Blood Pressure Management Based on Benefit and Adverse Events.
    Bress AP; Greene T; Derington CG; Shen J; Xu Y; Zhang Y; Ying J; Bellows BK; Cushman WC; Whelton PK; Pajewski NM; Reboussin D; Beddu S; Hess R; Herrick JS; Zhang Z; Kolm P; Yeh RW; Basu S; Weintraub WS; Moran AE;
    J Am Coll Cardiol; 2021 Apr; 77(16):1977-1990. PubMed ID: 33888247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Final Report of a Trial of Intensive versus Standard Blood-Pressure Control.
    ; Lewis CE; Fine LJ; Beddhu S; Cheung AK; Cushman WC; Cutler JA; Evans GW; Johnson KC; Kitzman DW; Oparil S; Rahman M; Reboussin DM; Rocco MV; Sink KM; Snyder JK; Whelton PK; Williamson JD; Wright JT; Ambrosius WT
    N Engl J Med; 2021 May; 384(20):1921-1930. PubMed ID: 34010531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Risk of Harm Associated With Intensive Blood Pressure Management Among Patients With Hypertension Who Smoke: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial.
    Scarpa J; Bruzelius E; Doupe P; Le M; Faghmous J; Baum A
    JAMA Netw Open; 2019 Mar; 2(3):e190005. PubMed ID: 30848803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalizing the Intensity of Blood Pressure Control: Modeling the Heterogeneity of Risks and Benefits From SPRINT (Systolic Blood Pressure Intervention Trial).
    Patel KK; Arnold SV; Chan PS; Tang Y; Pokharel Y; Jones PG; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2017 Apr; 10(4):. PubMed ID: 28373269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Hypertension Management Strategies in SPRINT-Eligible US Adults: A Simulation Study.
    Zhang F; Bryant KB; Moran AE; Zhang Y; Cohen JB; Bress AP; Sheppard JP; King JB; Derington CG; Weintraub WS; Kronish IM; Shea S; Bellows BK
    J Am Heart Assoc; 2024 Jan; 13(2):e032370. PubMed ID: 38214272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The SPRINT Research. A Randomized Trial of Intensive versus Standard Blood-Pressure Control].
    Widimský J
    Vnitr Lek; 2016 Jan; 62(1):44-7. PubMed ID: 26967236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Reboussin DM; Allen NB; Griswold ME; Guallar E; Hong Y; Lackland DT; Miller EPR; Polonsky T; Thompson-Paul AM; Vupputuri S
    Circulation; 2018 Oct; 138(17):e595-e616. PubMed ID: 30354656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial.
    Williamson JD; Supiano MA; Applegate WB; Berlowitz DR; Campbell RC; Chertow GM; Fine LJ; Haley WE; Hawfield AT; Ix JH; Kitzman DW; Kostis JB; Krousel-Wood MA; Launer LJ; Oparil S; Rodriguez CJ; Roumie CL; Shorr RI; Sink KM; Wadley VG; Whelton PK; Whittle J; Woolard NF; Wright JT; Pajewski NM;
    JAMA; 2016 Jun; 315(24):2673-82. PubMed ID: 27195814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using benefit-based tailored treatment to improve the use of antihypertensive medications.
    Sussman J; Vijan S; Hayward R
    Circulation; 2013 Nov; 128(21):2309-17. PubMed ID: 24190955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Cardiovascular Risk on the Relative Benefit and Harm of Intensive Treatment of Hypertension.
    Phillips RA; Xu J; Peterson LE; Arnold RM; Diamond JA; Schussheim AE
    J Am Coll Cardiol; 2018 Apr; 71(15):1601-1610. PubMed ID: 29525494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of initiation of antihypertensive therapy strategies for primary prevention of cardiovascular diseases in Chinese population: A decision-analytic Markov modelling study].
    Zhou T; Liu Q; Zhang M; Liu X; Kang J; Shen P; Lin H; Tang X; Gao P
    Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Jun; 56(3):441-447. PubMed ID: 38864129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of baseline systolic blood pressure on the relationship between intensive blood pressure control and cardiovascular outcomes in the Systolic Blood Pressure Intervention Trial (SPRINT).
    Sun X; Guo Y; Nie Z; Cheng J; Zhou H; Zhong X; Zhang S; Du Z; Zhuang X; Liao X
    Clin Res Cardiol; 2019 Mar; 108(3):273-281. PubMed ID: 30167807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Hypertension and Cardiovascular Risk According to Blood Pressure Thresholds Used for Diagnosis.
    Lamprea-Montealegre JA; Zelnick LR; Hall YN; Bansal N; de Boer IH
    Hypertension; 2018 Sep; 72(3):602-609. PubMed ID: 30354757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.